Why the study?
Does the implantable multichamber pump system (IMPS) improve hemodynamic parameters in a porcine model of acute cardiac failure and ventricular fibrillation?
Does the implantable multichamber pump system (IMPS) improve hemodynamic parameters in a porcine model of acute cardiac failure and ventricular fibrillation?
The IMPS, a novel mechanical circulatory support device without direct blood contact, effectively improved hemodynamics in a porcine model of acute heart failure and ventricular fibrillation.
Answers are grounded in this paper and cite their sources.
Supports IMPS development for bloodless support; leaves open translation to human acute heart failure.
This paper presents a new cardiac support device for left ventricular failure which consists of two inflatable bellows positioned dorsally and ventrally to the left ventricle. The implantable multichamber pump system (IMPS) is driven by a pneumatic pump system and controlled by a microcomputer using ECG-trigger and pacemaker modules. It was implanted via thoracotomy in 8 pigs. The circulatory parameters were measured in the animals on beta-blockers, with cardiac failure and in ventricular fibrillation with an activated (IMPS on) and deactivated (IMPS off) system. IMPS significantly increased the left ventricular pressure (LVPsys IMPS off: 63 +/- 6 mmHg vs IMPS on: 96 +/- 8 mmHg) and the blood pressure in the common carotid artery (BPca, IMPS off: 69/38 mmHg vs IMPS on: 95/40 mmHg). The IMPS proved to be highly efficient in the therapy of animals with acute cardiac failure and in ventricular fibrillation in the experimental model. Apart from its efficiency the advantages with this system are the ease of handling and its high biocompatibility due to the lack of contact with circulating blood.
No takes yet. Share an insight, caveat, or question.
Petzold et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: